Tissue engineered models of healthy and malignant human bone marrow

Area of Science:

• Biomedical Engineering
• Hematology
• Pharmacology

Background:

• Tissue engineering offers in vitro models for functional tissue recapitulation and predictive drug testing.
• Microphysiological systems, or "tissues on a chip," integrate multiple tissue types for advanced applications.
• These platforms hold significant potential for disease modeling and the development of novel therapeutics.

Purpose of the Study:

• To highlight advancements in tissue engineering for hematopoietic stem and progenitor cells.
• To explore the application of these engineered tissues in modeling bone marrow malignancies.
• To demonstrate how bioengineering improvements in one area of bone marrow research can benefit others.

Main Methods:

• Utilizing tissue engineering principles to create in vitro models of human tissues.
• Developing microphysiological platforms with vascular perfusion for interconnected tissue systems.
• Focusing on the hematopoietic stem and progenitor cell compartment and bone marrow malignancies.

Main Results:

• Engineered tissues on chips serve as valuable tools for ex vivo functional tissue recapitulation.
• These models facilitate predictive testing of drug efficacy and safety.
• Improvements in bioengineering methods show interconnected utility across different bone marrow research areas.

Conclusions:

• Tissue engineering provides powerful tools for understanding complex biological systems like the bone marrow.
• Advancements in "tissues on a chip" accelerate drug discovery and disease modeling.
• Interdisciplinary bioengineering approaches enhance the study of hematopoietic stem cells and bone marrow-related diseases.